Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2004 1
2005 3
2006 11
2007 6
2008 21
2009 23
2010 21
2011 14
2012 24
2013 26
2014 29
2015 31
2016 27
2017 18
2018 15
2019 12
2020 1
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

248 results

Results by year

Filters applied: . Clear all
Page 1
Human natural killer cells.
Caligiuri MA. Caligiuri MA. Blood. 2008 Aug 1;112(3):461-9. doi: 10.1182/blood-2007-09-077438. Blood. 2008. PMID: 18650461 Free PMC article. Review.
Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia.
Byrd JC, Harrington B, O'Brien S, Jones JA, Schuh A, Devereux S, Chaves J, Wierda WG, Awan FT, Brown JR, Hillmen P, Stephens DM, Ghia P, Barrientos JC, Pagel JM, Woyach J, Johnson D, Huang J, Wang X, Kaptein A, Lannutti BJ, Covey T, Fardis M, McGreivy J, Hamdy A, Rothbaum W, Izumi R, Diacovo TG, Johnson AJ, Furman RR. Byrd JC, et al. N Engl J Med. 2016 Jan 28;374(4):323-32. doi: 10.1056/NEJMoa1509981. Epub 2015 Dec 7. N Engl J Med. 2016. PMID: 26641137 Free PMC article. Clinical Trial.
Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia.
Byrd JC, Furman RR, Coutre SE, Flinn IW, Burger JA, Blum KA, Grant B, Sharman JP, Coleman M, Wierda WG, Jones JA, Zhao W, Heerema NA, Johnson AJ, Sukbuntherng J, Chang BY, Clow F, Hedrick E, Buggy JJ, James DF, O'Brien S. Byrd JC, et al. N Engl J Med. 2013 Jul 4;369(1):32-42. doi: 10.1056/NEJMoa1215637. Epub 2013 Jun 19. N Engl J Med. 2013. PMID: 23782158 Free PMC article. Clinical Trial.
Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.
Byrd JC, Brown JR, O'Brien S, Barrientos JC, Kay NE, Reddy NM, Coutre S, Tam CS, Mulligan SP, Jaeger U, Devereux S, Barr PM, Furman RR, Kipps TJ, Cymbalista F, Pocock C, Thornton P, Caligaris-Cappio F, Robak T, Delgado J, Schuster SJ, Montillo M, Schuh A, de Vos S, Gill D, Bloor A, Dearden C, Moreno C, Jones JJ, Chu AD, Fardis M, McGreivy J, Clow F, James DF, Hillmen P; RESONATE Investigators. Byrd JC, et al. N Engl J Med. 2014 Jul 17;371(3):213-23. doi: 10.1056/NEJMoa1400376. Epub 2014 May 31. N Engl J Med. 2014. PMID: 24881631 Free PMC article. Clinical Trial.
Signaling pathways involved in MDSC regulation.
Trikha P, Carson WE 3rd. Trikha P, et al. Biochim Biophys Acta. 2014 Aug;1846(1):55-65. doi: 10.1016/j.bbcan.2014.04.003. Epub 2014 Apr 13. Biochim Biophys Acta. 2014. PMID: 24727385 Free PMC article. Review.
Killer immunoglobulin-like receptors and tumor immunity.
Benson DM Jr, Caligiuri MA. Benson DM Jr, et al. Cancer Immunol Res. 2014 Feb;2(2):99-104. doi: 10.1158/2326-6066.CIR-13-0219. Cancer Immunol Res. 2014. PMID: 24592397 Free PMC article. Review.
Review of S100A9 biology and its role in cancer.
Markowitz J, Carson WE 3rd. Markowitz J, et al. Biochim Biophys Acta. 2013 Jan;1835(1):100-9. doi: 10.1016/j.bbcan.2012.10.003. Epub 2012 Nov 1. Biochim Biophys Acta. 2013. PMID: 23123827 Free PMC article. Review.
248 results